OneSource Speci.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE013P01021
  • NSEID: ONESOURCE
  • BSEID: 544292
INR
1,488.70
66.55 (4.68%)
BSENSE

Mar 06

BSE+NSE Vol: 3.96 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039523,
    "name": "OneSource Speci.",
    "stock_name": "OneSource Speci.",
    "full_name": "OneSource Specialty Pharma Ltd",
    "name_url": "stocks-analysis/onesource-speci",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,488.70",
    "chg": 66.55,
    "chgp": "4.68%",
    "dir": 1,
    "prev_price": "1,422.15",
    "mcapval": "16,438.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544292,
    "symbol": "ONESOURCE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE013P01021",
    "curr_date": "Mar 06",
    "curr_time": "",
    "bse_nse_vol": "3.96 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 06, 2026",
    "traded_date_str": "2026 03 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/onesource-speci-10039523-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "OneSource Specialty Pharma Gains 10.04%: 3 Key Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/onesource-specialty-pharma-gains-1004-3-key-factors-driving-the-week-3877689",
        "imagepath": "",
        "date": "2026-03-07 09:04:37",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Mar:</strong> Downgrade to Strong Sell amid weak financials and bearish technicals</p>\n                    <p><strong>4 Mar:</strong> Bearish momentum confirmed with technical downgrade and 4.14% price drop</p>\n                    <p><strong>5 Mar:</strong> Intraday high surge of 7.26% with strong volume and sector outperformance</p>\n                    <p><strong>6 Mar:</strong> Week closes at Rs.1,480.90, up 10.04% for the week despite mixed signals</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,345.75</div></div>\n                    <div class=\"s..."
      },
      {
        "title": "OneSource Specialty Pharma Ltd Hits Intraday High with 7.26% Surge on 5 March 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/onesource-specialty-pharma-ltd-hits-intraday-high-with-726-surge-on-5-march-2026-3873856",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/OneSourceSpecia_priceRelatedfactors_3873856.png",
        "date": "2026-03-05 15:16:01",
        "description": "OneSource Specialty Pharma Ltd demonstrated robust intraday performance on 5 Mar 2026, surging to a day’s high of Rs 1425.5, marking a 6.7% rise and closing the session with a notable 7.26% gain. This advance outpaced the broader Pharmaceuticals & Biotechnology sector by 5.43%, reflecting strong trading momentum amid a generally positive market backdrop."
      },
      {
        "title": "OneSource Specialty Pharma Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/onesource-specialty-pharma-ltd-faces-bearish-momentum-amid-technical-downgrade-3868461",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/OneSourceSpecia_technicaldot_3868461.png",
        "date": "2026-03-04 08:08:21",
        "description": "OneSource Specialty Pharma Ltd has experienced a marked shift in price momentum, with technical indicators signalling a bearish trend. The company’s shares closed at ₹1,290.00 on 4 Mar 2026, down 4.14% from the previous close of ₹1,345.75, reflecting growing investor caution amid deteriorating technical signals and a challenging market backdrop."
      },
      {
        "title": "OneSource Specialty Pharma Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/onesource-specialty-pharma-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3866121",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/OneSourceSpecia_mojoScore_3866121.png",
        "date": "2026-03-03 09:12:42",
        "description": "OneSource Specialty Pharma Ltd has been downgraded from a Sell to a Strong Sell rating following a comprehensive reassessment of its quality, valuation, financial trend, and technical indicators. The downgrade reflects deteriorating fundamentals, weak debt servicing ability, expensive valuation metrics, and a shift to bearish technical trends, signalling caution for investors amid challenging market conditions."
      },
      {
        "title": "When is the next results date for OneSource Specialty Pharma Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-onesource-specialty-pharma-ltd-3797134",
        "imagepath": "",
        "date": "2026-01-20 23:16:43",
        "description": "The next results date for OneSource Specialty Pharma Ltd is scheduled for January 23, 2026...."
      }
    ],
    "total": 185,
    "sid": "10039523",
    "stock_news_url": "https://www.marketsmojo.com/news/onesource-specialty-pharma-10039523"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "04-Mar-2026",
      "details": "Schedule of Analyst/Investors meet-Intimation under Regulation 30 of the SEBI Listing Regulations.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Regarding Receipt Of No Objection/ No Adverse Observation Letter From The National Stock Exchange Of India Limited / BSE Limited In Realation To The Draft Composite Scheme Of Arrangement And Amalgamation (Merger By Absorption).",
      "datetime": "26-Feb-2026",
      "details": "Intimation regarding receipt of Observation Letters from BSE and NSE.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "12-Feb-2026",
      "details": "Intimation of ESG Rating by SES ESG Research Private Limited",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

OneSource Specialty Pharma Gains 10.04%: 3 Key Factors Driving the Week

2026-03-07 09:04:37

Key Events This Week

2 Mar: Downgrade to Strong Sell amid weak financials and bearish technicals

4 Mar: Bearish momentum confirmed with technical downgrade and 4.14% price drop

5 Mar: Intraday high surge of 7.26% with strong volume and sector outperformance

6 Mar: Week closes at Rs.1,480.90, up 10.04% for the week despite mixed signals

stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

04-Mar-2026 | Source : BSE

Schedule of Analyst/Investors meet-Intimation under Regulation 30 of the SEBI Listing Regulations.

Intimation Regarding Receipt Of No Objection/ No Adverse Observation Letter From The National Stock Exchange Of India Limited / BSE Limited In Realation To The Draft Composite Scheme Of Arrangement And Amalgamation (Merger By Absorption).

26-Feb-2026 | Source : BSE

Intimation regarding receipt of Observation Letters from BSE and NSE.

Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

12-Feb-2026 | Source : BSE

Intimation of ESG Rating by SES ESG Research Private Limited

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available